Allied Academies
0 days
0 hours
0 minutes
0 seconds

Call for Abstracts

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Diseases of the central and peripheral nervous systems are considered neurological disorders. These conditions include neurological problems as a result of malnutrition, epilepsy, Alzheimer's disease, and other dementias, cerebrovascular diseases such as stroke, migraine, and other headache disorders, multiple sclerosis, Parkinson's disease, neuro infections, and brain tumors.

In 2020, the size of the worldwide neuroscience market was $36.5 billion. Looking ahead, IMARC Group projects that the market will increase at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2028, reaching $46.2 billion by 2031. Neurology is a rapidly evolving field, with ongoing research and development of new treatments and therapies. Advances in neuroscience and technology have led to an improved understanding of the brain and nervous system, and opened up new avenues for the diagnosis and treatment of neurological disorders.

Modern Neuroscience has several branches, such as affective neuroscience, behavioral neuroscience, cellular neuroscience, clinical neuroscience, cognitive neuroscience, cultural neuroscience, molecular neuroscience, and social neuroscience.

In recent days, so many people have been affected by Stroke, including infants. The stroke management market is divided into hospitals, diagnostic centres, outpatient surgical centres, and others. In 2021, the hospital sector has a market share of nearly 42 percent. Too many individuals lose their lives to strokes. How to prevent stroke, types of strokes, and other disorders can be elaborated through the Stroke 2025. The types of strokes are Brain stroke, pediatric stroke, Neonatal stroke, and Ischemic stroke.

Ischemic stroke is also called brain stroke. Because when the blood flow to a portion of the brain is blocked or diminished, brain tissue cannot get oxygen and nutrients, which results in an ischemic stroke. In minutes, brain cells start to degenerate. In recent years so many people have been affected by Ischemic stroke due to a lack of blood supply in the brain.

Dementia is a type of Neurological Disorder, It is a set of symptoms that substantially affect memory, thinking, and social abilities and are referred to as dementia when they significantly interfere with day-to-day functioning. Numerous conditions can cause dementia, even if there isn't one specific sickness that does.

Epilepsy is one of the Neurological disorders that cause seizures or periods of unusual behavior, abnormal brain activity sensations, and sometimes loss of awareness. Both men and women in all ethnic groups are affected by epilepsy. According to data from the World Health Organization, the average cost of healthcare per person globally in 2018 was USD 1,154.731. The cost of healthcare per person globally went from USD 784.313 in 2010 to USD 1,320.841 in 2019, with the United States as the top payer at USD 11,643.85 per capita in 2025.

In the field of medicine known as psychiatry, mental, emotional, and behavioral problems are identified, treated, and prevented. A psychiatrist is a medical specialist who focuses on mental health, notably substance use disorders.

The market for treatments for transthyretin amyloidosis was valued at USD 4.822 billion in 2020 and is projected to grow to USD 7.11 billion by 2025. The size of the worldwide market for amyloidosis treatments was estimated at USD 3.7 billion in 2018 and is projected to grow at a CAGR of 6.9% during the forecast period. Some of the reasons that will jointly drive the market are the expanding elderly population, the increased acceptance of innovative targeted treatments and transplantation, the introduction of biologics, and these.

In recent years Animal models Testing was such a trending topic in Neurology. The market for animal models was valued at USD 17.27 billion in 2019 and is anticipated to rise to USD 29.08 billion by 2025, at a CAGR of 10.29%. Neuroscience, pharmacology, toxicology, and genetics are just a few of the scientific areas that employ animal models. Animals including mice, rats, rabbits, dogs, and non-human primates are frequently utilized as models those will be briefly elaborated in Stroke Conference.

Peripheral nervous system disease called Guillain-Barre syndrome. During the projection period, 2021-2026, the Guillain-Barre Syndrome Market Study is expected to expand at a CAGR of 4.9%. The COVID-19 virus has a substantial effect on the market for Guillain-Barre syndrome (GBS) treatments.

Tremors, stiffness, bradykinesia (slow movement), and postural instability are all signs of Parkinson's disease. Other symptoms may include a loss of smell, sleep disturbances, constipation, depression, and cognitive impairment. The market for medications for Parkinson's disease was estimated to be worth $5.9 billion globally in 2025; it is anticipated to increase to $11.2 billion by 2028, with a CAGR of 6.8% from 2020 to 2035. Parkinson's disease is a neurodegenerative condition commonly known as idiopathic Parkinsonism.

Alzheimer's disease is a neurodegenerative disorder that affects the brain, causing a decline in cognitive function and memory loss. In older people, it is the most typical cause of dementia. The Global market rate for Alzheimer’s disease was estimated to be worth $4.3 billion in 2019 and $6.2 billion by 2023, with a CAGR of 6.3% during the period of 2019-2025.

Neuroimaging and neurosonology are both diagnostic tools used in the field of neurology to help visualize and study the structure and function of the brain and nervous system. Neuroimaging refers to a group of techniques used to create images of the brain and its structures. Neurosonolgy is one of the diagnostic tools that use ultrasound technology.

The market for neurodegenerative diseases was estimated to be worth USD 39,125 million in 2020, and it is anticipated to grow to USD 78,295 million by 2035, showing a CAGR of 6.2% during the projected period (2020–2035).

Treatment for Cerebrovascular disease depends on the underlying condition and the severity of the symptoms. Medications may be used to help prevent blood clots and reduce the risk of stroke or TIA, and surgery or endovascular procedures may be necessary to repair damaged blood vessels or prevent further damage. Cerebrovascular disease knowledge was very important these are briefly elaborated on the Stroke 2023.

For neonatal and pediatric stroke, respectively, the average adjusted 5-year expenditures are significant at $54,719 and $135,168. The average price of admission for a youngster with a stroke was $91,869. Neonatal stroke birth admission expenses were on average $49,633; when these prices were adjusted for control birth admission costs, the difference was just $5,792, indicating that the stroke was responsible for 87% of the expenditures.

Depending on the underlying reason, treatment for cognitive impairment may involve drugs to control symptoms, cognitive and behavioral therapy, lifestyle changes, and supportive care. Early detection and treatment of cognitive impairment are crucial because certain causes of it may be reversible if discovered and addressed quickly enough. The cognitive impairment will be explained in Stroke 2025.

The protective coating known as the myelin sheath, which covers nerve fibers in the central and peripheral nervous systems, is a structure that is harmed by a set of illnesses known as demyelinating diseases. Numerous symptoms, including muscular weakness, tingling or numbness in the limbs, issues with balance and coordination, as well as issues with vision and speech, can be brought on by these illnesses.

This market research study on the treatment of dementia and movement disorders offers insightful information on the market's response to COVID-19, which will assist businesses in assessing their strategic business plans. The researcher at Technavio projects that the market for treating dementia and mobility disorders would be worth USD 8.14 billion by 2030, growing at a CAGR of 7.95%.

A specialty of medicine called pediatric neurology is dedicated to identifying and treating neurological disorders in infants and children. Pediatric neurologists are medical professionals with specialized training in this area who are prepared to treat newborns, kids, and teenagers with neurological issues.

Neurotherapy, also known as neurofeedback or EEG biofeedback, is a type of therapy that uses real-time feedback from the brain to help individuals learn to regulate and control their brainwave activity. The market for Neurotherapy is anticipated to reach $ 1,236.6 million in 2021 and grow at a CAGR of 7.4% from 2021 to 2027.

Copyright © 2025 Allied Academies, All Rights Reserved.